Cargando…
Nme(2)Cas9‐mediated therapeutic editing in inhibiting angiogenesis after wet age‐related macular degeneration onset
BACKGROUND: Age‐related macular degeneration (AMD), particularly wet AMD characterised by choroidal neovascularization (CNV), is a leading cause of vision loss in the elderly. The hypoxia‐inducible factor‐1α (HIF‐1α)/vascular endothelial growth factor (VEGF)/VEGF receptor 2 (VEGFR2) pathway contribu...
Autores principales: | Hu, Sihui, Chen, Yuxi, Xie, Dongchun, Xu, Kan, Fu, Yunzhao, Chi, Wei, Liu, Haiying, Huang, Junjiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10440058/ https://www.ncbi.nlm.nih.gov/pubmed/37598400 http://dx.doi.org/10.1002/ctm2.1383 |
Ejemplares similares
-
NmeCas9 is an intrinsically high-fidelity genome-editing platform
por: Amrani, Nadia, et al.
Publicado: (2018) -
Engineered domain-inlaid Nme2Cas9 adenine base editors with increased on-target DNA editing and targeting scope
por: Zhao, Ding, et al.
Publicado: (2023) -
A novel approach in preventing vascular leakage and angiogenesis in wet age-related macular degeneration
por: Yamada, Kaori H.
Publicado: (2022) -
CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes
por: Liang, Puping, et al.
Publicado: (2015) -
Imaging of Wet Age-Related Macular Degeneration
por: Kenan, Damer
Publicado: (2016)